These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1713069)

  • 1. Pancarcinoma T and Tn epitopes: autoimmunogens and diagnostic markers that reveal incipient carcinomas and help establish prognosis.
    Springer GF; Desai PR; Wise W; Carlstedt SC; Tegtmeyer H; Stein R; Scanlon EF
    Immunol Ser; 1990; 53():587-612. PubMed ID: 1713069
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum diagnosis of cancer with monoclonal antibodies].
    Kannagi R
    Rinsho Byori; 1989 Jul; (Spec No 82):52-86. PubMed ID: 2575677
    [No Abstract]   [Full Text] [Related]  

  • 3. Pancreatic tumor antigens: diagnostic markers and targets for immunotherapy.
    Finn OJ
    Important Adv Oncol; 1992; ():61-77. PubMed ID: 1374733
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
    Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
    Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative immunohistochemical studies of the histopathology of the breast using monoclonal antibodies Lu-5 and b-12].
    Förster C; Bässler R
    Pathologe; 1991 Mar; 12(2):60-5. PubMed ID: 1711692
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prognostic markers in transitional carcinoma of the bladder].
    Blasco E; Gutiérrez-Hoyos A; Garrido C; Arozena F
    Arch Esp Urol; 1991; 44(1):47-52. PubMed ID: 2064423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fundamental and diagnostic role of T and Tn antigens in breast carcinoma at the earliest histologic stage and throughout.
    Springer GF; Desai PR; Robinson MK; Tegtmeyer H; Scanlon EF
    Prog Clin Biol Res; 1986; 204():47-70. PubMed ID: 2421349
    [No Abstract]   [Full Text] [Related]  

  • 8. Simple mucins (T, sialosyl-T, Tn and sialosyl-Tn) are not diagnostic for malignant breast lesions.
    Reed W; Bryne M; Clausen H; Dabelsteen E; Nesland JM
    Anticancer Res; 1994; 14(2B):609-15. PubMed ID: 7516636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Different expressions of various epitopes of the Thomsen-Friedenreich antigen in breast cancer cells. Immunohistochemical study with monoclonal antibodies against asialoglycophorin A].
    Bein G; Poschmann A; Seitz RC; Böcker W
    Verh Dtsch Ges Pathol; 1985; 69():218-21. PubMed ID: 2420088
    [No Abstract]   [Full Text] [Related]  

  • 10. Flow cytometric analysis of T and Tn epitopes on chronic lymphocytic leukemia cells.
    Aller CT; Kucuk O; Springer GF; Gilman-Sachs A
    Am J Hematol; 1996 May; 52(1):29-38. PubMed ID: 8638608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tn antigens and their significance in oncology.
    Lisowska E
    Acta Biochim Pol; 1995; 42(1):11-7. PubMed ID: 7653152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
    Schlom J; Weeks MO
    Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
    [No Abstract]   [Full Text] [Related]  

  • 13. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid.
    Devine PL; Clark BA; Birrell GW; Layton GT; Ward BG; Alewood PF; McKenzie IF
    Cancer Res; 1991 Nov; 51(21):5826-36. PubMed ID: 1718585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a monoclonal antibody (G9) reactive with an organ-specific, tumor-associated epitope of human colon carcinoma.
    Gold DV; Ishizaki G; Keller P; Lew K
    Cancer Res; 1989 Nov; 49(22):6412-8. PubMed ID: 2478283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mucin antigens: what are we measuring?
    Price MR; Briggs S; Scanlon MJ; Tendler SJ; Sibley PE; Hand CW
    Dis Markers; 1991; 9(3-4):205-12. PubMed ID: 1725974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers.
    Longenecker BM; Willans DJ; MacLean GD; Selvaraj S; Suresh MR; Noujaim AA
    J Natl Cancer Inst; 1987 Mar; 78(3):489-96. PubMed ID: 3469463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization and quality control of tumour marker assays.
    Ward AM
    Dis Markers; 1991; 9(3-4):127-32. PubMed ID: 1813205
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
    Zhang JY; Casiano CA; Peng XX; Koziol JA; Chan EK; Tan EM
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):136-43. PubMed ID: 12582023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT
    Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
    Bray KR; Koda JE; Gaur PK
    Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.